Rajeev Aurora
9Patents
1h-index
21Co-inventors
51Inventor score
Filing activity: Mar 20, 1998 → Sep 10, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6638750B1 | Methionine aminopeptidase type 3 | Human Necessities | 3 | Expired |
| US10111928B1 | Pulsed introduction of low-dose RANKL as a therapy for osteogenesis imperfecta | Human Necessities | 1 | Active |
| US9144599B2 | Suppression of bone loss by introducing FoxP3+ CD8 T-cells (TcREG) | Human Necessities | 1 | Active |
| US6245550A | Cytokine family member EF-7 | Human Necessities | 0 | Expired |
| US6953577B2 | Human methionine aminopeptidase type 3 | Human Necessities | 0 | Expired |
| US10745461B2 | Pulsed introduction of low-dose RANKL as a therapy for diet-induced atherosclerosis | Human Necessities | 0 | Active |
| US8793074B2 | Sequence covariance networks, methods and uses therefor | Emerging Cross-Sectional Technologies | 0 | Active |
| US10328123B2 | Pulsed introduction of low-dose RANKL as a therapy for atherosclerosis | Human Necessities | 0 | Active |
| US9713633B1 | Suppression of bone loss by introducing FoxP3+ CD8 T-cells (TcREG) | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.